|
[1]LUO J, JIN F.Recent advances in understanding the impact of intestinal microbiota on host behavior[J].Chin Sci Bull, 2014, 59 (22) :2169-2190. (in Chinese) 罗佳, 金锋.肠道菌群影响宿主行为的研究进展[J].科学通报, 2014, 59 (22) :2169-2190.
|
|
[2]YU LX, SCHWABE RF.The gut microbiome and liver cancer:mechanisms and clinical translation[J].Nat Rev Gastroenterol Hepatol, 2017, 14 (9) :527-539.
|
|
[3]KIZILTAS S.Toll-like receptors in pathophysiology of liver diseases[J].World J Hepatol, 2016, 8 (32) :1354-1369.
|
|
[4]WEI XP, GAO X, MA YJ.Relationship between small intestinal bacterial overgrowth and severity of with hepatitis B cirrhosis[J].J Clin Hepatol, 2016, 32 (4) :716-719. (in Chinese) 魏新朋, 高晓, 马英杰.乙型肝炎肝硬化患者小肠细菌过度生长与疾病严重程度的相关性[J].临床肝胆病杂志, 2016, 32 (4) :716-719.
|
|
[5]BENTEN D, WIEST R.Gut microbiome and intestinal barrier failure——the"Achilles heel"in hepatology?[J].J Hepatol, 2012, 56 (6) :1221-1223.
|
|
[6]WU ZW, XU KJ, LI LJ, et al.Investigation of intestinal bacterial translocation in 78 patients with cirrhosis after liver transplantation[J].Chin J Surg, 2006, 44 (21) :1456-1459. (in Chinese) 吴仲文, 徐凯进, 李兰娟, 等.78例肝硬化患者肠道细菌易位及其相关性研究[J].中华外科杂志, 2006, 44 (21) :1456-1459.
|
|
[7]RACANELLI V, REHERMANN B.The liver as an immunological organ[J].Hepatology, 2006, 43 (2 Suppl 1) :s54-s62.
|
|
[8]TAKEDA K, KAISHO T, AKIRA S.Toll-like receptors[J].Annu Rev Immunol, 2003, 21 (1) :335-376.
|
|
[9]DAPITO DH, MENCIN A, GWAK GY, et al.Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4[J].Cancer Cell, 2012, 21 (4) :504-516.
|
|
[10]YOON HY, YI HY.Liver cirrhosis mortality in the United States, 1970-2007 surveillance report#88:NIAAA homepage 2010[EB/OL].http://pubs.niaaa.nih.gov/publications/surveillance88/Cirr07.htm, 2017-12-7.
|
|
[11]REHM J, MATHERS C, POPOVA S, et al.Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders[J].Lancet, 2009, 373 (9682) :2223-2233.
|
|
[12]SANYAL AJ, YOON SK, LENCIONI R.The etiology of hepatocellular carcinoma and consequences for treatment[J].Oncologist, 2010, 15 (Suppl 4) :14-22.
|
|
[13]LIPPAI D, BALA S, CATALANO D, et al.Micro-RNA-155deficiency prevents alcohol-induced serum endotoxin increase and small bowel inflammation in mice[J].Alcohol Clin Exp Res, 2014, 38 (8) :2217-2224.
|
|
[14]PRADERE JP, TROEGER JS, DAPITO DH, et al.Toll-like receptor 4 and hepatic fibrogenesis[J].Semin Liver Dis, 2010, 30 (3) :232-244.
|
|
[15]SZABO G.Gut-liver axis in alcoholic liver disease[J].Gastroenterology, 2015, 148 (1) :30-36.
|
|
[16]UESUGI T, FROH M, ARTEEL GE, et al.Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice[J].Hepatology, 2001, 34 (1) :101-108.
|
|
[17]ADACHI Y, MOORE LE, BRADFORD BU, et al.Antibiotics prevent liver injury in rats following long-term exposure to ethanol[J].Gastroenterology, 1995, 108 (1) :218-224.
|
|
[18]FAN JG, FARRELL GC.Epidemiology of non-alcoholic fatty liver disease in China[J].J Hepatol, 2009, 50 (1) :204-210.
|
|
[19]MICHELOTTI GA, MACHADO MV, DIEHL AM.NAFLD, NASH and liver cancer[J].Nat Rev Gastroenterol Hepatol, 2013, 10 (11) :656.
|
|
[20]STREBA LA, VERE CC, ROGOVEANU I, et al.Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma:An open question[J].World J Gastroenterol, 2015, 21 (14) :4103-4110.
|
|
[21]ZHOU D, PAN Q, SHEN F, et al.Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota[J].Sci Rep, 2017, 7 (1) :1529.
|
|
[22]SPRUSS A, KANURI G, WAGNERBERGER S, et al.Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice[J].Hepatology, 2009, 50 (4) :1094-1104.
|
|
[23]PAPPO I, BERCOVIER H, BERRY EM, et al.Polymyxin B reduces total parenteral nutrition-associated hepatic steatosis by its antibacterial activity and by blocking deleterious effects of lipopolysaccharide[J].JPEN J Parenter Enteral Nutr, 1992, 16 (6) :529-532.
|
|
[24]PAPPO I, BECOVIER H, BERRY EM, et al.Polymyxin B reduces cecal flora, TNF production and hepatic steatosis during total parenteral nutrition in the rat[J].J Surg Res, 1991, 51 (2) :106-112.
|
|
[25]DRENICK EJ, FISLER J, JOHNSON D.Hepatic steatosis after intestinal bypass——prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition[J].Gastroenterology, 1982, 82 (3) :535-548.
|
|
[26]MIELE L, VALENZA V, LA TORRE G, et al.Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease[J].Hepatology, 2009, 49 (6) :1877-1887.
|
|
[27]BROERING R, LU M, SCHLAAK JF.Role of Toll-like receptors in liver health and disease[J].Clin Sci (Lond) , 2011, 121 (10) :415-426.
|
|
[28]SOARES JB, PIMENTEL-NUNES P, RONCON-ALBUQUERQUE R, et al.The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases[J].Hepatol Int, 2010, 4 (4) :659-672.
|
|
[29]KAO JH, CHEN DS.Global control of hepatitis B virus infection[J].Lancet Infect Dis, 2002, 2 (7) :395-403.
|
|
[30]CHEN DS.Fighting against viral hepatitis:Lessons from Taiwan[J].Hepatology, 2011, 54 (2) :381-392.
|
|
[31]CHEN MM, ZHENG JS, LIU YY, et al.Changes of intestinal microbiota in patients with chronic hepatitis B and liver cirrhosis[J].Acta Univ Med Anhui, 2015, 50 (5) :648-652. (in Chinese) 陈萌萌, 郑吉顺, 刘艳艳, 等.慢性乙型肝炎以及肝硬化患者肠道微生物研究[J].安徽医科大学学报, 2015, 50 (5) :648-652.
|
|
[32]LI LJ, WU ZW, MA WH, et al.Changes in intestinal microflora in patients with chronic severe hepatitis[J].Chin Med J, 2001, 114 (8) :86-89. (in Chinese) 李兰娟, 吴仲文, 马伟杭, 等.慢性重型肝炎患者肠道菌群变化及其作用的研究 (英文) [J].中华医学杂志, 2001, 114 (8) :86-89.
|
|
[33]DOLGANIUC A, NORKINA O, KODYS K, et al.Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection[J].Gastroenterology, 2007, 133 (5) :1627-1636.
|
|
[34] JIANG FM, LI XF, CHENG SQ, et al.Clinical significance of expression of TLR3 and TLR4 in liver tissue of patients with chronic hepatitis B[J].Int J Virol, 2017, 24 (3) :209-212. (in Chinese) 蒋福明, 李秀芬, 程书权, 等.慢性乙型肝炎患者肝组织Toll样受体3、4表达及其临床意义[J].国际病毒学杂志, 2017, 24 (3) :209-212.
|
|
[35]SOARES JB, PIMENTEL-NUNES P, AFONSO L, et al.Increased hepatic expression of TLR2 and TLR4 in the hepatic inflammation-fibrosis-carcinoma sequence[J].Innate Immun, 2012, 18 (5) :700-708.
|
|
[36]TORRE LA, BRAY F, SIEGEL RL, et al.Global cancer statistics, 2012[J].CA Cancer J Clin, 2015, 65 (2) :87-108.
|
|
[37]YU LX, YAN HX, LIU Q, et al.Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents[J].Hepatology, 2010, 52 (4) :1322-1333.
|
|
[38]JING YY, HAN ZP, SUN K, et al.Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide[J].BMC Med, 2012, 10:98.
|
|
[39]MACHIDA K, TSUKAMOTO H, MKRTCHYAN H, et al.Tolllike receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog[J].Proc Natl Acad Sci U S A, 2009, 106 (5) :1548-1553.
|
|
[40]ZHANG HL, YU LX, YANG W, et al.Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats[J].J Hepatol, 2012, 57 (4) :803-812.
|
|
[41]LI J, SUNG CY, LEE N, et al.Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice[J].Proc Natl Acad Sci U S A, 2016, 113 (9) :e1306-e1315.
|
DownLoad: